IOHEXOL

IOHEXOL was reported 8473 times

IOHEXOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CEREBRAL ARTERY STENT INSERTION 5 0.8333
1 INTRAVASCULAR GAS 6 0.6000
2 CONTRAST ENCEPHALOPATHY 62 0.2246
3 INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION 7 0.1458
4 CONTRAST MEDIA ALLERGY 261 0.1424
5 CONTRAST MEDIA REACTION 270 0.1143
6 RASH MACULOVESICULAR 6 0.1017
7 PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER 10 0.0962
8 MENINGITIS FUNGAL 21 0.0894
9 MENINGITIS CHEMICAL 19 0.0864
10 BURKHOLDERIA TEST POSITIVE 9 0.0726
11 INADVERTENT INJECTION AIR BUBBLE 9 0.0714
12 CONUS MEDULLARIS SYNDROME 3 0.0462
13 AIR EMBOLISM 21 0.0446
14 ANAPHYLACTOID SHOCK 19 0.0404
15 OXYGEN SATURATION IMMEASURABLE 4 0.0364
16 LARYNGEAL OBSTRUCTION 6 0.0328
17 EXTRAVASATION 133 0.0323
18 LARYNX IRRITATION 7 0.0299
19 SNEEZING 630 0.0281
20 HERPES SIMPLEX TEST POSITIVE 5 0.0251
21 FIXED DRUG ERUPTION 3 0.0246
22 LACRIMATION DISORDER 3 0.0246
23 PITUITARY APOPLEXY 4 0.0227
24 BLOOD PRESSURE IMMEASURABLE 33 0.0215
25 URTICARIA PAPULAR 5 0.0197
26 ANEURYSM RUPTURED 18 0.0196
27 LARYNGEAL DISCOMFORT 12 0.0188
28 TONGUE PRURITUS 16 0.0186
29 BLINDNESS CORTICAL 9 0.0184
30 NUCLEAR MAGNETIC RESONANCE IMAGING 3 0.0181
31 ENANTHEMA 10 0.0174
32 PRODUCT WITH QUALITY ISSUE ADMINISTERED 7 0.0157
33 AMAUROSIS 13 0.0154
34 DEAFNESS PERMANENT 3 0.0153
35 SPINAL EPIDURAL HAEMATOMA 9 0.0153
36 NASAL PRURITUS 19 0.0152
37 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 15 0.0141
38 OVERLAP SYNDROME 9 0.0129
39 WOUND INFECTION PSEUDOMONAS 4 0.0127
40 TONGUE PARALYSIS 9 0.0126
41 LARYNGEAL PAIN 5 0.0123
42 IODINE ALLERGY 4 0.0120
43 INTESTINAL ANGIOEDEMA 5 0.0104
44 RESUSCITATION 17 0.0102
45 RADIOISOTOPE SCAN ABNORMAL 7 0.0099
46 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 8 0.0097
47 CONTRAST MEDIA DEPOSITION 3 0.0095
48 RESPIRATORY TRACT OEDEMA 7 0.0094
49 FOAMING AT MOUTH 19 0.0094
50 ANAL SPHINCTER ATONY 4 0.0093
51 DISCONTINUED PRODUCT ADMINISTERED 3 0.0091
52 LARYNGEAL OEDEMA 56 0.0091
53 NASAL OBSTRUCTION 17 0.0091
54 PNEUMONIA ESCHERICHIA 3 0.0088
55 ORAL PRURITUS 20 0.0087
56 CIRCUMORAL OEDEMA 3 0.0086
57 PATIENT UNCOOPERATIVE 4 0.0084
58 PULSE ABNORMAL 20 0.0083
59 RASH MACULO-PAPULAR 181 0.0081
60 ANAPHYLACTIC SHOCK 203 0.0079
61 THROAT TIGHTNESS 212 0.0078
62 EXTRADURAL HAEMATOMA 10 0.0076
63 NEUROGENIC SHOCK 4 0.0074
64 ARACHNOIDITIS 5 0.0072
65 INFUSION SITE EXTRAVASATION 45 0.0072
66 DYSPHORIA 36 0.0071
67 ANAPHYLACTOID REACTION 29 0.0070
68 KOUNIS SYNDROME 16 0.0070
69 PHARYNGEAL PARAESTHESIA 11 0.0069
70 SUSPECTED PRODUCT CONTAMINATION 7 0.0069
71 STRIDOR 20 0.0068
72 POST THROMBOTIC SYNDROME 3 0.0067
73 NUCHAL RIGIDITY 6 0.0066
74 GENERALISED ERYTHEMA 37 0.0065
75 CEREBRAL HYPOPERFUSION 3 0.0064
76 SKIN TEST POSITIVE 6 0.0064
77 THYROTOXIC CRISIS 7 0.0062
78 HYPERPYREXIA 26 0.0061
79 URTICARIA 1021 0.0061
80 SENSATION OF FOREIGN BODY 51 0.0060
81 TACHYPNOEA 82 0.0060
82 DISORGANISED SPEECH 11 0.0060
83 CONJUNCTIVAL HYPERAEMIA 21 0.0059
84 PARAPLEGIA 17 0.0059
85 PULSE ABSENT 28 0.0059
86 GAZE PALSY 10 0.0059
87 COLONIC ABSCESS 5 0.0058
88 CONJUNCTIVAL OEDEMA 6 0.0058
89 LIP PRURITUS 5 0.0058
90 ANAPHYLACTIC REACTION 322 0.0058
91 INFECTIOUS COLITIS 3 0.0057
92 INCORRECT PRODUCT FORMULATION ADMINISTERED 5 0.0056
93 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 7 0.0056
94 NEPHROGENIC SYSTEMIC FIBROSIS 17 0.0056
95 INDURATION 10 0.0056
96 MENINGITIS BACTERIAL 8 0.0056
97 AMAUROSIS FUGAX 6 0.0056
98 MANUFACTURING PRODUCT SHIPPING ISSUE 3 0.0055
99 THROAT IRRITATION 248 0.0055
100 TONGUE OEDEMA 21 0.0055
101 PAPULE 38 0.0054
102 NEPHROPATHY TOXIC 60 0.0053
103 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 14 0.0053
104 EYELID OEDEMA 62 0.0053
105 PORTAL HYPERTENSIVE GASTROPATHY 3 0.0053
106 MOANING 6 0.0053
107 PARAESTHESIA ORAL 76 0.0053
108 HYPORESPONSIVE TO STIMULI 6 0.0051
109 RASH MORBILLIFORM 14 0.0050
110 PHARYNGEAL SWELLING 49 0.0050
111 CYANOSIS 78 0.0050
112 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 127 0.0049
113 LIVEDO RETICULARIS 10 0.0048
114 GASTROINTESTINAL EROSION 3 0.0047
115 DERMATITIS EXFOLIATIVE GENERALISED 16 0.0046
116 GASTROINTESTINAL MUCOSAL DISORDER 3 0.0046
117 MENINGITIS ASEPTIC 20 0.0045
118 EOSINOPHILIA 77 0.0044
119 CARBON DIOXIDE DECREASED 5 0.0043
120 METHAEMOGLOBINAEMIA 10 0.0043
121 ADENOCARCINOMA GASTRIC 4 0.0043
122 VENOUS INJURY 4 0.0043
123 INTERVERTEBRAL DISCITIS 8 0.0042
124 GLASSY EYES 3 0.0042
125 PRODUCT CONTAMINATION MICROBIAL 5 0.0042
126 TOXIC SKIN ERUPTION 42 0.0042
127 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 32 0.0041
128 LIP EROSION 3 0.0041
129 INJECTION SITE OEDEMA 7 0.0041
130 CEREBRAL VASOCONSTRICTION 3 0.0041
131 HYPERAEMIA 8 0.0041
132 PATENT DUCTUS ARTERIOSUS 16 0.0040
133 TYPE IV HYPERSENSITIVITY REACTION 11 0.0040
134 INDIFFERENCE 3 0.0040
135 SKIN OEDEMA 4 0.0040
136 RENAL TUBULAR NECROSIS 39 0.0040
137 HAEMANGIOMA OF LIVER 4 0.0040
138 LIP DISCOLOURATION 5 0.0040
139 HYPERAESTHESIA TEETH 5 0.0040
140 SLOW RESPONSE TO STIMULI 5 0.0039
141 DRUG CLEARANCE DECREASED 5 0.0038
142 OEDEMA MUCOSAL 4 0.0038
143 HYPOPERFUSION 4 0.0038
144 BRONCHOSPASM 53 0.0037
145 IIIRD NERVE PARALYSIS 3 0.0037
146 SIALOADENITIS 5 0.0037
147 OXYGEN THERAPY 6 0.0036
148 RASH PUSTULAR 26 0.0036
149 PHARYNGEAL OEDEMA 53 0.0034
150 OROPHARYNGEAL DISCOMFORT 31 0.0034
151 ABDOMINAL SEPSIS 3 0.0034
152 BUNDLE BRANCH BLOCK LEFT 14 0.0033
153 MENINGITIS 22 0.0033
154 ENTEROCOLITIS INFECTIOUS 3 0.0033
155 PHARYNGEAL HYPOAESTHESIA 3 0.0032
156 FACE OEDEMA 54 0.0032
157 RENAL TUBULAR DISORDER 9 0.0032
158 UNRESPONSIVE TO STIMULI 82 0.0032
159 HYPOPNOEA 11 0.0032
160 ORTHOPNOEA 10 0.0031
161 FEAR OF DEATH 7 0.0031
162 VOMITING PROJECTILE 9 0.0031
163 TEMPERATURE INTOLERANCE 32 0.0031
164 CHILLS 360 0.0031
165 LIP OEDEMA 13 0.0031
166 VENTRICULAR FIBRILLATION 34 0.0031
167 QUADRIPARESIS 5 0.0030
168 ANION GAP INCREASED 4 0.0030
169 LARYNGOSPASM 8 0.0030
170 FIXED ERUPTION 5 0.0029
171 RHONCHI 4 0.0029
172 PULSELESS ELECTRICAL ACTIVITY 12 0.0029
173 ERYTHEMA 586 0.0028
174 EAR SWELLING 6 0.0028
175 VENTRICULAR HYPOKINESIA 9 0.0028
176 SHOCK 64 0.0028
177 EYE MOVEMENT DISORDER 19 0.0028
178 PALLOR 75 0.0028
179 HENOCH-SCHONLEIN PURPURA 6 0.0027
180 ESSENTIAL HYPERTENSION 5 0.0027
181 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 9 0.0027
182 BLOOD PRESSURE DECREASED 180 0.0027
183 EYE PRURITUS 91 0.0027
184 ACUTE PULMONARY OEDEMA 15 0.0027
185 MIXED LIVER INJURY 8 0.0027
186 YAWNING 7 0.0026
187 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
188 EYE SWELLING 97 0.0026
189 MOUTH SWELLING 15 0.0026
190 MEAN CELL VOLUME DECREASED 4 0.0026
191 NEPHROGENIC ANAEMIA 12 0.0026
192 PAROTITIS 3 0.0026
193 RESPIRATORY DISTRESS 71 0.0026
194 EAR PRURITUS 9 0.0026
195 DRY THROAT 26 0.0026
196 PROCALCITONIN INCREASED 3 0.0026
197 COLD SWEAT 45 0.0026
198 CHEST DISCOMFORT 261 0.0025
199 RESPIRATORY RATE DECREASED 8 0.0025
200 OXYGEN SATURATION DECREASED 143 0.0025
201 PRODUCT CONTAMINATION 9 0.0025
202 LYMPHADENITIS 6 0.0025
203 RESPIRATORY ALKALOSIS 4 0.0025
204 MONOCYTE COUNT DECREASED 3 0.0025
205 INJECTION RELATED REACTION 4 0.0024
206 PRURITUS 929 0.0024
207 SWOLLEN TONGUE 74 0.0024
208 NEUROGENIC BLADDER 5 0.0024
209 HYPERTHERMIA 18 0.0024
210 CHOKING SENSATION 13 0.0024
211 SEIZURE LIKE PHENOMENA 4 0.0024
212 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 9 0.0024
213 ANAL INCONTINENCE 21 0.0023
214 BLOOD CHLORIDE INCREASED 4 0.0023
215 COMPARTMENT SYNDROME 6 0.0023
216 LIP SWELLING 76 0.0023
217 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 5 0.0023
218 RASH VESICULAR 11 0.0023
219 DRUG ERUPTION 40 0.0023
220 ERYTHEMA OF EYELID 12 0.0022
221 DERMATITIS BULLOUS 16 0.0022
222 PUPILLARY REFLEX IMPAIRED 4 0.0022
223 RESPIRATORY RATE INCREASED 19 0.0021
224 DYSPHONIA 125 0.0021
225 THROAT CLEARING 8 0.0021
226 SKIN TIGHTNESS 10 0.0021
227 LISTLESS 7 0.0021
228 AUDITORY DISORDER 3 0.0021
229 CIRCULATORY COLLAPSE 36 0.0021
230 RASH ERYTHEMATOUS 101 0.0021
231 INJECTION SITE EXTRAVASATION 26 0.0021
232 NASAL CONGESTION 123 0.0021
233 DERMATITIS ALLERGIC 26 0.0021
234 PULMONARY SEPSIS 3 0.0021
235 ANGIOEDEMA 91 0.0021
236 EYE OEDEMA 5 0.0020
237 ERYTHEMA MULTIFORME 19 0.0020
238 PRURITUS GENERALISED 44 0.0020
239 BLINDNESS TRANSIENT 15 0.0020
240 LACRIMATION INCREASED 61 0.0020
241 EMPYEMA 4 0.0020
242 HYPERPARATHYROIDISM SECONDARY 5 0.0020
243 TYPE I HYPERSENSITIVITY 7 0.0020
244 OBSTRUCTIVE AIRWAYS DISORDER 22 0.0020
245 ACUTE KIDNEY INJURY 299 0.0020
246 PERIORBITAL SWELLING 11 0.0019
247 APNOEA 15 0.0019
248 HYPOAESTHESIA ORAL 29 0.0019
249 HYPERLACTACIDAEMIA 5 0.0019
250 URINARY INCONTINENCE 54 0.0018
251 CARDIO-RESPIRATORY ARREST 76 0.0018
252 HEPATIC CYTOLYSIS 23 0.0018
253 HYPERTHYROIDISM 26 0.0018
254 BACTERIAL TEST POSITIVE 4 0.0018
255 ENDOTRACHEAL INTUBATION 5 0.0018
256 CHRONIC GASTRITIS 4 0.0018
257 ACUTE RESPIRATORY FAILURE 34 0.0018
258 SWELLING FACE 115 0.0018
259 SWELLING OF EYELID 11 0.0018
260 PERIORBITAL OEDEMA 9 0.0017
261 DYSPHAGIA 162 0.0017
262 HICCUPS 14 0.0017
263 RESPIRATORY ARREST 47 0.0017
264 GASTROINTESTINAL OEDEMA 3 0.0017
265 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
266 EOSINOPHIL COUNT INCREASED 14 0.0017
267 URINARY HESITATION 4 0.0017
268 SKIN REACTION 23 0.0016
269 PNEUMONIA KLEBSIELLA 3 0.0016
270 PORTAL HYPERTENSION 5 0.0016
271 ALTERED STATE OF CONSCIOUSNESS 35 0.0016
272 SUFFOCATION FEELING 4 0.0016
273 CARDIAC ARREST 132 0.0016
274 BRAIN OEDEMA 20 0.0016
275 RALES 9 0.0015
276 LIPOMA 4 0.0015
277 SPINAL CORD COMPRESSION 6 0.0015
278 BLOOD PRESSURE SYSTOLIC DECREASED 7 0.0015
279 OEDEMA MOUTH 5 0.0015
280 LOCALISED OEDEMA 7 0.0015
281 ARTHRITIS INFECTIVE 7 0.0015
282 ODYNOPHAGIA 9 0.0015
283 ARTERIOSPASM CORONARY 6 0.0015
284 HYPOPHYSITIS 3 0.0015
285 TACHYCARDIA 131 0.0015
286 PNEUMOTHORAX 23 0.0014
287 PLEURITIC PAIN 4 0.0014
288 PETECHIAE 15 0.0014
289 LUNG CONSOLIDATION 4 0.0014
290 BREATH SOUNDS ABNORMAL 7 0.0014
291 STAPHYLOCOCCAL SEPSIS 7 0.0014
292 HYPERVOLAEMIA 7 0.0014
293 DEPRESSED LEVEL OF CONSCIOUSNESS 56 0.0014
294 CHOLECYSTITIS ACUTE 8 0.0014
295 OCULAR HYPERAEMIA 67 0.0014
296 DYSPNOEA 799 0.0014
297 HYPOTENSION 282 0.0014
298 NEPHROPATHY 13 0.0014
299 FLUSHING 141 0.0014
300 TOXIC EPIDERMAL NECROLYSIS 21 0.0014
301 TONGUE DISORDER 10 0.0014
302 FEELING HOT 84 0.0014
303 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
304 ASTHMATIC CRISIS 5 0.0014
305 HYPOVOLAEMIA 8 0.0014
306 RENAL FAILURE ACUTE 58 0.0014
307 LOSS OF CONSCIOUSNESS 174 0.0014
308 TRISMUS 7 0.0014
309 PRODUCT ADMINISTRATION ERROR 27 0.0013
310 VENTRICULAR TACHYCARDIA 22 0.0013
311 WRONG PRODUCT ADMINISTERED 9 0.0013
312 GASTRIC POLYPS 3 0.0013
313 PROTEIN TOTAL DECREASED 5 0.0013
314 SERUM FERRITIN INCREASED 7 0.0013
315 VARICES OESOPHAGEAL 4 0.0013
316 CRANIOCEREBRAL INJURY 4 0.0013
317 WHEEZING 78 0.0013
318 HYPOXIA 46 0.0013
319 DYSAESTHESIA 4 0.0013
320 EYELID DISORDER 3 0.0013
321 HYPERSENSITIVITY 241 0.0013
322 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 22 0.0013
323 BLISTER 72 0.0013
324 BLOOD CREATININE DECREASED 4 0.0013
325 SUBARACHNOID HAEMORRHAGE 13 0.0013
326 RESPIRATORY ACIDOSIS 5 0.0013
327 APHASIA 38 0.0013
328 HYPERBILIRUBINAEMIA 13 0.0013
329 HYPOVOLAEMIC SHOCK 6 0.0013
330 PANIC REACTION 9 0.0012
331 PERIPHERAL COLDNESS 17 0.0012
332 PRODUCT PACKAGING CONFUSION 3 0.0012
333 TUBULOINTERSTITIAL NEPHRITIS 23 0.0012
334 LYMPHOCYTE COUNT INCREASED 4 0.0012
335 RETCHING 26 0.0012
336 ARTHRITIS BACTERIAL 5 0.0012
337 COUGH 338 0.0012
338 ASPIRATION 13 0.0012
339 CARDIOGENIC SHOCK 17 0.0012
340 HAEMOPTYSIS 33 0.0012
341 ACIDOSIS 9 0.0012
342 PURULENT DISCHARGE 5 0.0012
343 HEPATOSPLENOMEGALY 3 0.0012
344 METABOLIC ACIDOSIS 37 0.0012
345 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
346 RIGHT VENTRICULAR FAILURE 8 0.0011
347 EMBOLIC STROKE 4 0.0011
348 ABDOMINAL ABSCESS 5 0.0011
349 PHYSICAL DISABILITY 5 0.0011
350 LUNG TRANSPLANT 4 0.0011
351 MULTIPLE ORGAN DYSFUNCTION SYNDROME 32 0.0011
352 OLIGURIA 7 0.0011
353 HAEMORRHAGE SUBCUTANEOUS 4 0.0011
354 MONOCYTE COUNT INCREASED 4 0.0011
355 CLONUS 3 0.0011
356 BLOOD PHOSPHORUS DECREASED 4 0.0011
357 INTESTINAL ISCHAEMIA 6 0.0011
358 PARADOXICAL DRUG REACTION 4 0.0011
359 HYPOTHERMIA 11 0.0011
360 HEART RATE DECREASED 38 0.0011
361 MACULE 3 0.0011
362 FEELING COLD 30 0.0011
363 CARDIAC DYSFUNCTION 4 0.0011
364 LEUKOENCEPHALOPATHY 4 0.0011
365 EAR DISCOMFORT 11 0.0011
366 DISSEMINATED INTRAVASCULAR COAGULATION 15 0.0011
367 HYPERHIDROSIS 137 0.0011
368 SINUS TACHYCARDIA 15 0.0011
369 FACIAL PARALYSIS 9 0.0011
370 TROPONIN INCREASED 8 0.0011
371 VOMITING 494 0.0010
372 GENERALISED OEDEMA 13 0.0010
373 NEUROLOGICAL SYMPTOM 6 0.0010
374 CYTOKINE RELEASE SYNDROME 21 0.0010
375 FAECAL INCONTINENCE 5 0.0010
376 ENTEROCOLITIS 6 0.0010
377 COMA SCALE ABNORMAL 3 0.0010
378 STEVENS-JOHNSON SYNDROME 23 0.0010
379 HAEMOTHORAX 3 0.0010
380 SKIN WARM 6 0.0010
381 BILIARY COLIC 3 0.0010
382 GINGIVAL BLEEDING 14 0.0010
383 PURPURA 9 0.0010
384 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 6 0.0010
385 NEUROLEPTIC MALIGNANT SYNDROME 12 0.0010
386 HEPATITIS FULMINANT 3 0.0010
387 HAEMOLYTIC ANAEMIA 9 0.0010
388 ATYPICAL PNEUMONIA 3 0.0010
389 AZOTAEMIA 4 0.0010
390 CREATININE RENAL CLEARANCE DECREASED 4 0.0010
391 RASH 430 0.0010
392 AMMONIA INCREASED 5 0.0010
393 PERIPHERAL VENOUS DISEASE 4 0.0010
394 PARALYSIS 14 0.0010
395 RASH PRURITIC 53 0.0010
396 ENCEPHALOPATHY 24 0.0010
397 ENDOCARDITIS 5 0.0010
398 CEREBRAL ISCHAEMIA 5 0.0010
399 RESPIRATORY DISORDER 29 0.0010
400 RASH GENERALISED 25 0.0010
401 BLOOD CREATININE INCREASED 63 0.0010
402 SKIN NECROSIS 5 0.0010
403 FAILURE TO THRIVE 5 0.0010
404 EYELIDS PRURITUS 3 0.0010
405 FLANK PAIN 9 0.0010
406 HAEMODIALYSIS 8 0.0010
407 FOREIGN BODY IN THROAT 3 0.0010
408 BLOOD LACTIC ACID INCREASED 5 0.0009
409 NON-CARDIAC CHEST PAIN 3 0.0009
410 MYDRIASIS 12 0.0009
411 ABNORMAL SENSATION IN EYE 4 0.0009
412 POSTURE ABNORMAL 3 0.0009
413 HAEMODYNAMIC INSTABILITY 7 0.0009
414 VITREOUS FLOATERS 9 0.0009
415 BURNING SENSATION 64 0.0009
416 HAEMOLYSIS 7 0.0009
417 CARDIAC FAILURE ACUTE 6 0.0009
418 COAGULOPATHY 15 0.0009
419 STREPTOCOCCAL INFECTION 5 0.0009
420 HEART RATE INCREASED 89 0.0009
421 HEART RATE ABNORMAL 5 0.0009
422 SMALL INTESTINAL OBSTRUCTION 11 0.0009
423 METASTASES TO SPINE 3 0.0009
424 OEDEMA 48 0.0009
425 LEUKOCYTOSIS 16 0.0009
426 HYPERKALAEMIA 31 0.0009
427 HEPATIC CYST 3 0.0009
428 NASAL DISCOMFORT 7 0.0009
429 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
430 ECCHYMOSIS 6 0.0009
431 SEIZURE 101 0.0009
432 PRIAPISM 3 0.0009
433 SENSORY LOSS 7 0.0009
434 DROOLING 6 0.0009
435 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
436 MUSCLE TWITCHING 20 0.0009
437 MUSCLE TIGHTNESS 14 0.0009
438 PRESYNCOPE 21 0.0009
439 FORMICATION 6 0.0009
440 ELECTROLYTE IMBALANCE 10 0.0009
441 PRODUCT LABEL CONFUSION 5 0.0009
442 SWELLING 80 0.0009
443 MUSCLE CONTRACTIONS INVOLUNTARY 3 0.0009
444 FEELING OF BODY TEMPERATURE CHANGE 5 0.0009
445 ACUTE CORONARY SYNDROME 7 0.0008
446 BACTERAEMIA 10 0.0008
447 LIVER FUNCTION TEST INCREASED 18 0.0008
448 BODY TEMPERATURE INCREASED 17 0.0008
449 TREMOR 138 0.0008
450 BRADYCARDIA 44 0.0008
451 END STAGE RENAL DISEASE 15 0.0008
452 BLOOD MAGNESIUM DECREASED 7 0.0008
453 HYPERTENSIVE CRISIS 9 0.0008
454 CHOLANGITIS 5 0.0008
455 ABDOMINAL TENDERNESS 4 0.0008
456 RASH PAPULAR 18 0.0008
457 HYPERNATRAEMIA 4 0.0008
458 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 6 0.0008
459 DERMATITIS EXFOLIATIVE 4 0.0008
460 TUMOUR LYSIS SYNDROME 7 0.0008
461 PARANASAL SINUS DISCOMFORT 3 0.0008
462 LOSS OF CONTROL OF LEGS 3 0.0008
463 VULVOVAGINAL PRURITUS 4 0.0008
464 TOXIC ENCEPHALOPATHY 4 0.0008
465 COMMUNICATION DISORDER 3 0.0008
466 FOREIGN BODY SENSATION IN EYES 5 0.0008
467 SEPTIC SHOCK 34 0.0008
468 PHLEBITIS 4 0.0008
469 INCREASED UPPER AIRWAY SECRETION 4 0.0008
470 GAIT INABILITY 26 0.0008
471 OCCUPATIONAL EXPOSURE TO PRODUCT 5 0.0008
472 BLOOD UREA INCREASED 13 0.0008
473 EYE DISCHARGE 8 0.0008
474 PYREXIA 266 0.0008
475 TENDON DISORDER 5 0.0008
476 PALPITATIONS 89 0.0008
477 INCONTINENCE 8 0.0008
478 BLOOD ALBUMIN DECREASED 6 0.0008
479 CHOLECYSTITIS 9 0.0008
480 MUSCLE RIGIDITY 9 0.0008
481 ATRIAL FLUTTER 6 0.0008
482 DELIRIUM 26 0.0007
483 INTRACRANIAL ANEURYSM 3 0.0007
484 RESPIRATORY FAILURE 54 0.0007
485 BLOOD BILIRUBIN INCREASED 20 0.0007
486 PULMONARY OEDEMA 33 0.0007
487 ASPHYXIA 6 0.0007
488 HYDROCEPHALUS 4 0.0007
489 ATELECTASIS 7 0.0007
490 RENAL FAILURE 96 0.0007
491 PNEUMONIA ASPIRATION 18 0.0007
492 ORAL DISCOMFORT 10 0.0007
493 URINARY RETENTION 24 0.0007
494 NECROSIS 4 0.0007
495 RHINORRHOEA 46 0.0007
496 HEPATOCELLULAR INJURY 10 0.0007
497 INTERNAL HAEMORRHAGE 8 0.0007
498 ANURIA 6 0.0007
499 PERICARDIAL EFFUSION 16 0.0007
500 HYPERVENTILATION 4 0.0007
501 DISCOMFORT 42 0.0007
502 CHEST PAIN 127 0.0007
503 NEUROTOXICITY 12 0.0007
504 NAUSEA 538 0.0007
505 LACTIC ACIDOSIS 22 0.0007
506 HEAD DISCOMFORT 12 0.0007
507 PLEURISY 4 0.0007
508 HAEMORRHAGE INTRACRANIAL 10 0.0007
509 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
510 CEREBRAL INFARCTION 16 0.0007
511 ISCHAEMIA 3 0.0007
512 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
513 IRON DEFICIENCY ANAEMIA 6 0.0006
514 HEMIPARESIS 11 0.0006
515 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
516 DYSARTHRIA 24 0.0006
517 INFUSION SITE SWELLING 4 0.0006
518 NO ADVERSE EVENT 114 0.0006
519 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
520 ENTERITIS 4 0.0006
521 POST PROCEDURAL COMPLICATION 12 0.0006
522 OCULAR DISCOMFORT 7 0.0006
523 BLOOD CALCIUM DECREASED 7 0.0006
524 ISCHAEMIC STROKE 11 0.0006
525 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
526 MICTURITION URGENCY 7 0.0006
527 MENTAL STATUS CHANGES 17 0.0006
528 EMBOLISM 5 0.0006
529 HYPOTONIA 6 0.0006
530 HYPERAMMONAEMIA 3 0.0006
531 BRAIN INJURY 6 0.0006
532 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
533 CORONARY ARTERY STENOSIS 3 0.0006
534 SEPSIS 66 0.0006
535 TINNITUS 27 0.0006
536 SKIN DISCOLOURATION 27 0.0006
537 NEUTROPHIL COUNT INCREASED 6 0.0006
538 PRODUCT COLOUR ISSUE 3 0.0006
539 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
540 NEPHROTIC SYNDROME 4 0.0006
541 DISORIENTATION 23 0.0006
542 RESPIRATION ABNORMAL 4 0.0006
543 COLITIS 22 0.0006
544 SYNCOPE 58 0.0006
545 ASCITES 17 0.0006
546 ENCEPHALITIS 4 0.0006
547 SKIN SWELLING 5 0.0006
548 TENDERNESS 6 0.0006
549 ATRIAL FIBRILLATION 56 0.0006
550 APHONIA 8 0.0006
551 URINE OUTPUT DECREASED 5 0.0006
552 SPINAL OSTEOARTHRITIS 5 0.0006
553 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
554 HYPOAESTHESIA 84 0.0006
555 SENSORY DISTURBANCE 9 0.0006
556 COMPRESSION FRACTURE 3 0.0006
557 THIRST 10 0.0006
558 FEBRILE NEUTROPENIA 37 0.0006
559 BLOOD PRESSURE INCREASED 85 0.0006
560 CHRONIC KIDNEY DISEASE 42 0.0006
561 OSTEOMYELITIS 10 0.0006
562 DYSSTASIA 16 0.0005
563 RESTLESSNESS 20 0.0005
564 TRANSAMINASES INCREASED 12 0.0005
565 INTRACRANIAL PRESSURE INCREASED 3 0.0005
566 FEELING DRUNK 4 0.0005
567 HEPATIC ENCEPHALOPATHY 5 0.0005
568 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
569 MULTIPLE USE OF SINGLE-USE PRODUCT 3 0.0005
570 HYPONATRAEMIA 30 0.0005
571 STATUS EPILEPTICUS 6 0.0005
572 ARTERIOSCLEROSIS 5 0.0005
573 NEUTROPHILIA 3 0.0005
574 COMA 25 0.0005
575 HYPERTONIA 3 0.0005
576 PROCEDURAL COMPLICATION 4 0.0005
577 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
578 MUSCULAR WEAKNESS 59 0.0005
579 STAPHYLOCOCCAL INFECTION 17 0.0005
580 DIZZINESS 257 0.0005
581 EJECTION FRACTION DECREASED 8 0.0005
582 PULMONARY HAEMORRHAGE 4 0.0005
583 BRAIN FOG 8 0.0005
584 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
585 HEPATOMEGALY 5 0.0005
586 THERAPY CHANGE 5 0.0005
587 BODY TEMPERATURE DECREASED 5 0.0005
588 MYOCLONUS 6 0.0005
589 DIPLOPIA 13 0.0005
590 SALIVARY HYPERSECRETION 5 0.0005
591 SPEECH DISORDER 26 0.0005
592 PANIC ATTACK 18 0.0005
593 POST PROCEDURAL INFECTION 4 0.0005
594 MOTOR DYSFUNCTION 5 0.0005
595 PANCREATITIS ACUTE 11 0.0005
596 DYSURIA 18 0.0005
597 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
598 BACK PAIN 113 0.0005
599 PIGMENTATION DISORDER 3 0.0005
600 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
601 SPINAL COMPRESSION FRACTURE 4 0.0005
602 PHARYNGITIS 6 0.0005
603 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
604 HEMIPLEGIA 4 0.0005
605 PNEUMONITIS 13 0.0005
606 ACUTE MYOCARDIAL INFARCTION 14 0.0005
607 PHOTOPSIA 3 0.0005
608 SCRATCH 5 0.0005
609 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
610 ASPARTATE AMINOTRANSFERASE INCREASED 25 0.0005
611 HAEMOGLOBIN ABNORMAL 3 0.0005
612 BREAST CANCER METASTATIC 5 0.0005
613 HIATUS HERNIA 6 0.0005
614 FEELING ABNORMAL 111 0.0005
615 AGITATION 34 0.0005
616 GROIN PAIN 4 0.0005
617 METASTASES TO LIVER 8 0.0005
618 HYPOKALAEMIA 21 0.0005
619 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
620 HAEMATOCRIT DECREASED 9 0.0005
621 NERVE INJURY 5 0.0004
622 LIVER INJURY 11 0.0004
623 NECK PAIN 25 0.0004
624 PLEURAL EFFUSION 27 0.0004
625 ALANINE AMINOTRANSFERASE INCREASED 27 0.0004
626 ABSCESS 7 0.0004
627 PARAESTHESIA 69 0.0004
628 PNEUMONIA BACTERIAL 4 0.0004
629 HAEMATEMESIS 11 0.0004
630 MEDICATION ERROR 24 0.0004
631 HYPERTRANSAMINASAEMIA 3 0.0004
632 DERMATITIS 9 0.0004
633 RASH MACULAR 15 0.0004
634 HEPATIC FUNCTION ABNORMAL 16 0.0004
635 DEFAECATION URGENCY 3 0.0004
636 MOUTH ULCERATION 9 0.0004
637 SEASONAL ALLERGY 6 0.0004
638 LYMPHADENOPATHY 15 0.0004
639 JOINT STIFFNESS 11 0.0004
640 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
641 IMPAIRED QUALITY OF LIFE 6 0.0004
642 SINUS BRADYCARDIA 4 0.0004
643 EAR PAIN 8 0.0004
644 CHOKING 8 0.0004
645 MELAENA 9 0.0004
646 RESPIRATORY DEPRESSION 5 0.0004
647 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
648 ABDOMINAL PAIN 94 0.0004
649 PERIPHERAL SWELLING 62 0.0004
650 DRY EYE 20 0.0004
651 VISION BLURRED 55 0.0004
652 EYE IRRITATION 23 0.0004
653 PREMATURE BABY 12 0.0004
654 PANCREATITIS 21 0.0004
655 EMPHYSEMA 4 0.0004
656 CONFUSIONAL STATE 64 0.0004
657 ECONOMIC PROBLEM 6 0.0004
658 ABDOMINAL PAIN LOWER 10 0.0004
659 MYALGIA 67 0.0004
660 HYPERTENSION 83 0.0004
661 LIPASE INCREASED 3 0.0004
662 EYE PAIN 22 0.0004
663 PULMONARY EMBOLISM 37 0.0004
664 ELECTROCARDIOGRAM QT PROLONGED 14 0.0004
665 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
666 LUNG INFECTION 6 0.0004
667 HAEMATOMA 10 0.0004
668 HAEMORRHAGIC STROKE 3 0.0004
669 MUCOSAL INFLAMMATION 10 0.0004
670 TRANSFUSION 4 0.0004
671 VERTIGO 23 0.0004
672 CONJUNCTIVITIS 7 0.0004
673 JOINT RANGE OF MOTION DECREASED 5 0.0004
674 QUALITY OF LIFE DECREASED 5 0.0004
675 HEPATIC CIRRHOSIS 7 0.0004
676 PHOTOPHOBIA 7 0.0004
677 RENAL INJURY 11 0.0004
678 SINUS CONGESTION 5 0.0004
679 IMPAIRED GASTRIC EMPTYING 5 0.0004
680 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
681 POLYURIA 3 0.0004
682 ACUTE HEPATIC FAILURE 5 0.0004
683 MUSCULOSKELETAL STIFFNESS 32 0.0004
684 EYE DISORDER 12 0.0004
685 DRUG INTERACTION 57 0.0004
686 COORDINATION ABNORMAL 5 0.0004
687 OROPHARYNGEAL PAIN 33 0.0004
688 INFUSION SITE ERYTHEMA 3 0.0004
689 SKIN EXFOLIATION 30 0.0004
690 CARDIOVASCULAR DISORDER 9 0.0004
691 MALAISE 155 0.0004
692 DERMATITIS CONTACT 4 0.0004
693 HYPOGLYCAEMIA 17 0.0004
694 SCAR 6 0.0004
695 PSEUDOMONAS INFECTION 3 0.0003
696 SKIN ULCER 9 0.0003
697 CARDIAC MURMUR 3 0.0003
698 DYSKINESIA 14 0.0003
699 DEAFNESS 9 0.0003
700 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
701 SPLENOMEGALY 4 0.0003
702 CARDIOMYOPATHY 5 0.0003
703 PULMONARY HYPERTENSION 7 0.0003
704 PULMONARY MASS 5 0.0003
705 RENAL IMPAIRMENT 28 0.0003
706 HEADACHE 208 0.0003
707 HEPATIC FAILURE 10 0.0003
708 NEURALGIA 8 0.0003
709 PLATELET COUNT DECREASED 35 0.0003
710 CARDIOMEGALY 4 0.0003
711 ANAEMIA 62 0.0003
712 HYPERCALCAEMIA 4 0.0003
713 FAECES DISCOLOURED 7 0.0003
714 HEPATIC STEATOSIS 6 0.0003
715 PANCYTOPENIA 18 0.0003
716 SKIN BURNING SENSATION 23 0.0003
717 BLOOD SODIUM DECREASED 6 0.0003
718 CELLULITIS 16 0.0003
719 INFUSION RELATED REACTION 21 0.0003
720 ARRHYTHMIA 15 0.0003
721 PROTEINURIA 6 0.0003
722 PRODUCTIVE COUGH 15 0.0003
723 GASTROOESOPHAGEAL REFLUX DISEASE 25 0.0003
724 PLATELET COUNT INCREASED 4 0.0003
725 ECZEMA 16 0.0003
726 PULMONARY CONGESTION 4 0.0003
727 DRUG LEVEL INCREASED 5 0.0003
728 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
729 ASTHENIA 113 0.0003
730 ABORTION SPONTANEOUS 12 0.0003
731 OEDEMA PERIPHERAL 36 0.0003
732 EYELID PTOSIS 3 0.0003
733 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 5 0.0003
734 RIB FRACTURE 6 0.0003
735 BLOOD PRESSURE FLUCTUATION 7 0.0003
736 MULTI-ORGAN FAILURE 5 0.0003
737 LOCAL SWELLING 5 0.0003
738 THROMBOCYTOPENIA 32 0.0003
739 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
740 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
741 LYMPHOCYTE COUNT DECREASED 5 0.0003
742 LYMPHOPENIA 4 0.0003
743 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
744 EATING DISORDER 6 0.0003
745 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
746 IRRITABLE BOWEL SYNDROME 6 0.0003
747 RED BLOOD CELL COUNT DECREASED 8 0.0003
748 SUBDURAL HAEMATOMA 4 0.0003
749 HOT FLUSH 21 0.0003
750 LETHARGY 16 0.0003
751 DECREASED ACTIVITY 3 0.0003
752 CARDIAC FAILURE 22 0.0003
753 HYPOPHAGIA 7 0.0003
754 DYSGEUSIA 20 0.0003
755 COLON CANCER 4 0.0003
756 INTESTINAL PERFORATION 3 0.0003
757 BLOOD POTASSIUM DECREASED 8 0.0003
758 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
759 HYPOCALCAEMIA 5 0.0003
760 CONVULSION 15 0.0003
761 EPILEPSY 8 0.0003
762 DEVICE RELATED INFECTION 4 0.0003
763 COGNITIVE DISORDER 12 0.0003
764 DEHYDRATION 34 0.0003
765 COVID-19 PNEUMONIA 3 0.0003
766 DISABILITY 5 0.0003
767 ATAXIA 3 0.0003
768 DIVERTICULITIS 7 0.0003
769 SINUS DISORDER 5 0.0003
770 INFLAMMATION 13 0.0003
771 CEREBRAL HAEMORRHAGE 9 0.0003
772 GASTROINTESTINAL HAEMORRHAGE 21 0.0003
773 HYPERLIPIDAEMIA 3 0.0003
774 HYPOTHYROIDISM 8 0.0003
775 LOCALISED INFECTION 6 0.0002
776 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
777 BONE MARROW FAILURE 5 0.0002
778 CYTOPENIA 3 0.0002
779 HYPERSOMNIA 7 0.0002
780 PAIN 145 0.0002
781 NEUTROPENIA 32 0.0002
782 MUSCLE SPASMS 43 0.0002
783 HAEMATURIA 8 0.0002
784 INFUSION SITE PAIN 3 0.0002
785 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
786 MUSCULOSKELETAL DISCOMFORT 4 0.0002
787 ABDOMINAL DISTENSION 24 0.0002
788 MENTAL DISORDER 10 0.0002
789 INJECTION SITE PAIN 70 0.0002
790 AMENORRHOEA 4 0.0002
791 ORAL CANDIDIASIS 3 0.0002
792 LIVER DISORDER 10 0.0002
793 NERVOUS SYSTEM DISORDER 7 0.0002
794 FREQUENT BOWEL MOVEMENTS 6 0.0002
795 HEART RATE IRREGULAR 5 0.0002
796 NEUTROPHIL COUNT DECREASED 9 0.0002
797 C-REACTIVE PROTEIN INCREASED 8 0.0002
798 HYPERGLYCAEMIA 8 0.0002
799 PAIN IN EXTREMITY 64 0.0002
800 BACTERIAL INFECTION 4 0.0002
801 DYSPNOEA EXERTIONAL 8 0.0002
802 PAIN IN JAW 6 0.0002
803 DIALYSIS 3 0.0002
804 GASTRIC ULCER 4 0.0002
805 MUSCULOSKELETAL DISORDER 4 0.0002
806 DRY MOUTH 17 0.0002
807 EXPOSURE DURING PREGNANCY 13 0.0002
808 PULMONARY FIBROSIS 4 0.0002
809 ARTHRALGIA 86 0.0002
810 DYSTONIA 4 0.0002
811 FLUID OVERLOAD 3 0.0002
812 IMMUNODEFICIENCY 3 0.0002
813 INFECTION 29 0.0002
814 DEEP VEIN THROMBOSIS 13 0.0002
815 SOMNOLENCE 40 0.0002
816 OSTEOPENIA 3 0.0002
817 DEVICE FAILURE 3 0.0002
818 DIARRHOEA 127 0.0002
819 ABDOMINAL DISCOMFORT 33 0.0002
820 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
821 MUSCULOSKELETAL CHEST PAIN 3 0.0002
822 NERVOUSNESS 10 0.0002
823 DRUG-INDUCED LIVER INJURY 6 0.0002
824 ANHEDONIA 5 0.0002
825 EMOTIONAL DISTRESS 23 0.0002
826 ANXIETY 54 0.0002
827 BRONCHITIS 14 0.0002
828 JOINT INJURY 4 0.0002
829 RECTAL HAEMORRHAGE 8 0.0002
830 INJURY 13 0.0002
831 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
832 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
833 FATIGUE 142 0.0002
834 SKIN LESION 5 0.0002
835 PNEUMONIA 59 0.0002
836 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
837 VIRAL INFECTION 6 0.0002
838 ORAL PAIN 4 0.0002
839 TOXICITY TO VARIOUS AGENTS 30 0.0002
840 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
841 CANDIDA INFECTION 3 0.0002
842 CHROMATURIA 4 0.0002
843 ABNORMAL BEHAVIOUR 7 0.0002
844 HAEMOGLOBIN DECREASED 18 0.0002
845 ANGINA PECTORIS 5 0.0002
846 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
847 BLINDNESS 7 0.0002
848 WITHDRAWAL SYNDROME 7 0.0002
849 DIABETIC KETOACIDOSIS 4 0.0002
850 IRRITABILITY 10 0.0002
851 GASTROENTERITIS VIRAL 3 0.0002
852 BLOOD GLUCOSE INCREASED 31 0.0002
853 ACCIDENTAL OVERDOSE 6 0.0002
854 HAEMATOCHEZIA 9 0.0002
855 GAIT DISTURBANCE 31 0.0002
856 LIMB DISCOMFORT 5 0.0002
857 AGRANULOCYTOSIS 3 0.0002
858 EXTRAPYRAMIDAL DISORDER 4 0.0002
859 ASTHMA 18 0.0002
860 URINARY TRACT INFECTION 27 0.0002
861 HEPATITIS 4 0.0002
862 HERNIA 3 0.0002
863 PRESCRIBED OVERDOSE 3 0.0002
864 KIDNEY INFECTION 3 0.0002
865 MUSCULOSKELETAL PAIN 8 0.0002
866 GASTRITIS 4 0.0002
867 BLOOD PRESSURE ABNORMAL 3 0.0002
868 EXPIRED PRODUCT ADMINISTERED 5 0.0002
869 FEAR 4 0.0001
870 FEEDING DISORDER 3 0.0001
871 PRODUCT QUALITY ISSUE 20 0.0001
872 EPISTAXIS 11 0.0001
873 MALIGNANT NEOPLASM PROGRESSION 15 0.0001
874 ARTHROPATHY 8 0.0001
875 POLLAKIURIA 6 0.0001
876 INJECTION SITE SWELLING 11 0.0001
877 DEVICE MALFUNCTION 10 0.0001
878 SLEEP DISORDER 10 0.0001
879 PANCREATIC CARCINOMA 4 0.0001
880 AMNESIA 9 0.0001
881 GENERAL PHYSICAL HEALTH DETERIORATION 16 0.0001
882 BONE PAIN 8 0.0001
883 ABDOMINAL PAIN UPPER 28 0.0001
884 CEREBROVASCULAR ACCIDENT 23 0.0001
885 FALL 45 0.0001
886 OFF LABEL USE 118 0.0001
887 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
888 DECREASED APPETITE 31 0.0001
889 CONSTIPATION 29 0.0001
890 CORONARY ARTERY DISEASE 4 0.0001
891 HEPATIC ENZYME INCREASED 9 0.0001
892 CONDITION AGGRAVATED 40 0.0001
893 INJECTION SITE RASH 4 0.0001
894 DISTURBANCE IN ATTENTION 7 0.0001
895 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
896 VISUAL IMPAIRMENT 16 0.0001
897 DISEASE PROGRESSION 15 0.0001
898 CYSTITIS 4 0.0001
899 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
900 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
901 MENTAL IMPAIRMENT 3 0.0001
902 LUNG DISORDER 6 0.0001
903 HERPES ZOSTER 7 0.0001
904 AGEUSIA 3 0.0001
905 SKIN DISORDER 4 0.0001
906 RHABDOMYOLYSIS 5 0.0001
907 AGGRESSION 6 0.0001
908 DEPRESSION 27 0.0001
909 GASTRIC CANCER 3 0.0001
910 PRODUCT COMPLAINT 3 0.0001
911 ERECTILE DYSFUNCTION 3 0.0001
912 ILLNESS 12 0.0001
913 JOINT SWELLING 14 0.0001
914 NEOPLASM PROGRESSION 4 0.0001
915 HAEMORRHAGE 12 0.0001
916 CONTUSION 11 0.0001
917 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
918 COLITIS ULCERATIVE 5 0.0001
919 JAUNDICE 3 0.0001
920 PAIN OF SKIN 3 0.0001
921 THERAPY NON-RESPONDER 5 0.0001
922 LIMB INJURY 3 0.0001
923 MOOD ALTERED 3 0.0001
924 CARDIAC DISORDER 10 0.0001
925 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
926 NEUROPATHY PERIPHERAL 10 0.0001
927 BLOOD GLUCOSE DECREASED 5 0.0001
928 BALANCE DISORDER 9 0.0001
929 LIVER FUNCTION TEST ABNORMAL 3 0.0001
930 PLASMA CELL MYELOMA 4 0.0001
931 LEUKOPENIA 5 0.0001
932 CARDIAC FAILURE CONGESTIVE 8 0.0001
933 DRUG ADMINISTRATION ERROR 3 0.0001
934 OSTEOPOROSIS 4 0.0001
935 FEMUR FRACTURE 3 0.0001
936 BONE DENSITY DECREASED 3 0.0001
937 OSTEOARTHRITIS 4 0.0001
938 HALLUCINATION 7 0.0001
939 VAGINAL HAEMORRHAGE 4 0.0001
940 FUNGAL INFECTION 3 0.0001
941 INJECTION SITE ERYTHEMA 11 0.0001
942 THROMBOSIS 7 0.0001
943 ADVERSE EVENT 8 0.0001
944 NIGHTMARE 3 0.0001
945 RENAL DISORDER 4 0.0001
946 SURGERY 5 0.0001
947 HOSPITALISATION 13 0.0001
948 MYELOSUPPRESSION 3 0.0001
949 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
950 ACNE 6 0.0001
951 SINUSITIS 8 0.0001
952 DEVICE ISSUE 7 0.0001
953 DEPRESSED MOOD 4 0.0001
954 DEVICE BREAKAGE 3 0.0001
955 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
956 INJECTION SITE REACTION 5 0.0001
957 DYSPEPSIA 7 0.0001
958 FLATULENCE 4 0.0001
959 HYPOACUSIS 3 0.0001
960 PRODUCT USE ISSUE 13 0.0001
961 DRUG INEFFECTIVE 90 0.0001
962 WEIGHT DECREASED 19 0.0001
963 DRY SKIN 9 0.0001
964 UNEVALUABLE EVENT 5 0.0001
965 MEMORY IMPAIRMENT 9 0.0001
966 BLOOD CHOLESTEROL INCREASED 3 0.0001
967 INSOMNIA 17 0.0001
968 ARTHRITIS 5 0.0001
969 MYOCARDIAL INFARCTION 11 0.0001
970 INTERSTITIAL LUNG DISEASE 3 0.0001
971 INFLUENZA LIKE ILLNESS 5 0.0001
972 DEATH 52 0.0001
973 INJECTION SITE PRURITUS 4 0.0001
974 FLUID RETENTION 3 0.0001
975 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
976 DERMATITIS ATOPIC 3 0.0001
977 THERAPY INTERRUPTED 4 0.0001
978 GASTROINTESTINAL DISORDER 5 0.0001
979 MOBILITY DECREASED 4 0.0001
980 ADVERSE DRUG REACTION 5 0.0001
981 OVERDOSE 12 0.0001
982 INFLUENZA 6 0.0001
983 MIGRAINE 5 0.0001
984 COVID-19 9 0.0001
985 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
986 DRUG DEPENDENCE 8 0.0000
987 NASOPHARYNGITIS 9 0.0000
988 PRODUCT DOSE OMISSION ISSUE 14 0.0000
989 ALOPECIA 8 0.0000
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
991 INJECTION SITE BRUISING 3 0.0000
992 INJECTION SITE HAEMORRHAGE 3 0.0000
993 PROSTATE CANCER 3 0.0000
994 INCORRECT DOSE ADMINISTERED 6 0.0000